V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
Vol. 36 No.2 • 4/2019
DAILY CLINICAL LAB NEWS
®
I
N
T
E
Tau Blood Test for Alzheimer’s Disease
R
N
A
T
I
O
Newborn Genomic Sequencing Detects Disease Risk Factors
resently, the only way to definitively diagnose Alzheimer’s disease is through brain scans and tests of cerebrospinal fluid collected via lumbar puncture. Though cumbersome and expensive, such procedures provide the most accurate diagnoses for patients.
P
enomic sequencing provides many opportunities in newborn clinical care, but the challenges of interpreting and reporting newborn genomic sequencing (nGS) results need to be addressed for their broader and effective application.
G
Recent advances in genomic sequencing (GS) have raised the possibility of its routine implementation in newborn care. Newborn GS (nGS) provides many potential opportunities in the clinical management of a newborn. First, it might identify risk for a broad
Cont’d on page 7
Cont’d on page 8
Phenotypic Test Identifies Antibiotic-Resistant Bacterial Infections
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
Image: Courtesy of iQ Group Global
iquid biopsy for plasma circulating tumor DNA (ctDNA) next-generation sequencing (NGS) is commercially available and increasingly adopted in clinical practice despite a paucity of prospective data to support its use. Plasma ctDNA harboring somatic mutations are highly specific for cancer and may serve as a useful surrogate of tumor burden, intratumor heterogeneity, and
L
rostate cancer (PCa) is one of the most common types of malignancy worldwide and is the second leading cause of cancer death among men. This cancer tends to be asymptomatic and slow growing, often with onset in young men, but usually not detected until the age of 40 to 50 years. The conventional methods for PCa screening recommended by the American Cancer Society are Cont’d on page 4
Advanced System Brings Integrated Solution to Clinical Flow Cytometry
INSIDE
he newly-launched ClearLLab 10C clinical flow cytometry system offers an integrated solution, featuring standardized workflow that delivers greater consistency and reliability in clinical findings, and simplifies clinical QC reporting.
Clinical News . . . . 4-26 IFCC News . . . . . . . . 27 Product News . . 10-26 Industry News . . . . 33 Events Calendar . . . 34
P O R T A L
Renew /Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information:
T
See article on page 8
Transfusions with Older Blood Linked to Adverse Events
Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 Click to reach reader service portal
3
Liquid Biopsy Identifies Lung Cancer Drivers
P
See article on page 4
S
L
Urinary Detection Method For Prostate Cancer
C
I
A
Cont’d on page 5
arbapenemase-Producing Organisms (CPO) are gramnegative bacteria that are resistant to antibiotics for severe or high-risk bacterial infections. Instead of manual detection that took up to four days, the CPO Detect test can now offer results in less than 36 hours, enabling earlier implementation of infection control and therapy procedures.
V
N
Mark code(s) of interest on LinkXpress ® inquiry matrix
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
fter a serious injury, the leading cause of death is loss of blood. Major trauma victims who receive transfusions of packed blood 22 days old or older may face increased risk of death within 24 hours, according to a new study. A blood transfusion is a safe,
A
common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. Major trauma victims can require massive transfusions of blood or blood products in a very short time. Clinical effects of stored blood toxicity include Cont’d on page 6
PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<